Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 29 Rituximab (nur Fertigarzneimittel)
openTechniker Krankenkasse · 992-80116-93
Value
unstated
Published
2 Nov 2026
Deadline
30 Nov 2028, 22:58 GMT
Type
opportunity
33600000 · Medical equipment, pharmaceuticals & personal careDE600
Description
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130c Abs. 1 SGB V zu dem Wirkstoff Rituximab (nur Fertigarzneimittel exklusive Darreichungsform zur subkutanen Injektion) zu schließen.
Key facts
- Procedure
- open
- Contact
- DZEM@tk.de
- Contract period
- 1 Dec 2026 → 30 Nov 2028
- Bids opened
- 30 Nov 2028, 22:59 GMT
- Regime
- publicSector
- Category
- supplies
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- Calendar export — the deadline as a calendar file
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- ted-eu
- Notice id
- 759317-2026
- First seen
- 2 Nov 2026
- Last updated
- 2 Nov 2026
Licence EU reuse — Commission Decision 2011/833/EU ↗
Source: TED — Tenders Electronic Daily (ted.europa.eu), © European Union, reused under Commission Decision 2011/833/EU.
View at source ↗
GET /api/v1/tenders/3d89ce31-2b33-4b62-810a-601fa0b7bf1aThe source notice is authoritative — verify deadlines and documents there before bidding.